European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome

Conditions: Alport Syndrome; Hereditary Kidney Disease; Pediatric Kidney Disease; Thin Basement Membrane Disease; Familial Benign HematuriaInterventions: Drug: ACE-inhibitor; Drug: AT1-inhibitor; Drug: HMG-Coenzyme inhibitor (statin); Drug: Spironolactone; Drug: ParicalcitolSponsors: University Hospital Goettingen; Gesellschaft für Pädiatrische Nephrologie; Deutsche Gesellschaft für Nephrologie; Alport Selbsthilfe e.V.; Association pour l'Information et la Recherche sur les Maladies Rénales Génétiques (AIRG); KfH Foundation Preventive MedicineRecruiting - verified February 2015

http://clinicaltrials.gov/ct2/show/NCT02378805?lup_s=02%2F15%2F2015&lup_d=30

Source: ClinicalTrials.gov - February 26, 2015 Category: Research Source Type: clinical trials